APA

Valette H., Dollé F., Guenther I., Demphel S., Rasetti C., Hinnen F., Fuseau C. & Crouzel C. (19990802). Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET. : Nuclear medicine and biology.

Chicago

Valette H, Dollé F, Guenther I, Demphel S, Rasetti C, Hinnen F, Fuseau C and Crouzel C. 19990802. Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET. : Nuclear medicine and biology.

Harvard

Valette H., Dollé F., Guenther I., Demphel S., Rasetti C., Hinnen F., Fuseau C. and Crouzel C. (19990802). Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET. : Nuclear medicine and biology.

MLA

Valette H, Dollé F, Guenther I, Demphel S, Rasetti C, Hinnen F, Fuseau C and Crouzel C. Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET. : Nuclear medicine and biology. 19990802.